Certified by Founder Lodge
NG Bio
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $1,781,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At NG Bio we build therapeutic ventures that can change outcomes for patients with autoimmune and chronic inflammatory diseases. Our team of scientists, drug developers and entrepreneurs work
Mesenbio
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
